Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

Список литературы

  1. Burnett M, Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 2017;39:585–95.
  2. Berkley K. Primary dysmenorrhea: An urgent mandate. International Association for the Study of Pain, 2013. Available at www.academia.edu/71348227/Primary_dysmenorrhea_An_urgent_mandate
  3. Ferries-Rowe E, Corey E, Archer JS. Primary dysmenorrhea: Diagnosis and therapy. Obstet Gynecol 2020;136(5):1047–58. doi: 10.1097/AOG.0000000000004096. 
  4. Armour M, Parry K, Manohar N, et al. The prevalence and academic impact of dysmenorrhea in 21,573 young women: A systematic review and meta-analysis. J Womens Health (Larchmt) 2019;28(8):1161–71. doi: 10.1089/jwh.2018.7615. 
  5. De Sanctis V, Soliman A, Bernasconi S, et al. Primary dysmenorrhea in adolescents: Prevalence, impact and recent knowledge. Pediatr Endocrinol Rev 2015;13(2):512–20. 
  6. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: A critical review. Hum Reprod Update 2015;21(6):762–78. doi: 10.1093/humupd/dmv039. 
  7. Starrs AM, Ezeh AC, Barker G, et al. Accelerate progress – Sexual and reproductive rights and rights for all: Report of the Guttmacher–Lancet Commission. Lancet 2018;391(10140):2642–92. doi: 10.1016/S0140-6736(18)30293-9. 
  8. McKenna KA, Fogleman CD. Dysmenorrhea. Am Fam Physician 2021;104(2):164–70. 
  9. Berkley K. Primary dysmenorrhea: An urgent mandate. International Association for the Study of Pain, 2013. Available at www.academia.edu/71348227/Primary_dysmenorrhea_An_urgent_mandate [Accessed 25 April 2023]. 
  10. Ortiz MI, Espinoza-Ramírez AL, Cariño-Cortés R, Moya-Escalera A. Impacto de la dismenorrea primaria en el rendimiento académico de estudiantes universitarios [Impact of primary dysmenorrhea on the academic performance of university students]. Enferm Clin (Engl Ed). 2022 Sep-Oct;32(5):351-357. Spanish. doi: 10.1016/j.enfcle.2021.12.007. 
  11. Jarrell JF, Vilos GA, Allaire C, et al. Consensus guidelines for the management of chronic pelvic pain. J Obstet Gynaecol Can 2005;27:869e910.
  12. Taran FA, Stewart EA, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives tohysterectomy. Geburtshilfe Frauenheilkd 2013;73:924e31.
  13. Laufer MR. Helping “adult gynecologists” diagnose and treat adolescent endometriosis: reflections on my 20 years of personal experience. J Pediatr Adolesc Gynecol 2011 Oct:24(5 Suppl):S13-7. http://dx.doi.org/10.1016/j.jpag.2011.07.005.
  14. Manganaro L., Fierro F., Tomei A., Irimia D. et al. Feasibility of 3.0T pelvic MR imaging in the evaluation of endometriosis. Eur. J. Radiol. 2012; 81(6): 1381–7. DOI: 10.1016/j.ejrad.2011.03.049
  15. Thomeer M.G., Steensma A.B., van Santbrink E.J., Willemssen F.E. et al. Can magnetic resonance imaging at 3.0–Tesla reliably detect patients with endometriosis? Initial results. J. Obstet. Gynaecol. Res. 2014; 40(4): 1051–8. DOI: 10.1111/jog.12290
  16. ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Human Reproduction Open, Volume 2022, Issue 2, 2022, hoac009, doi:10.1093/hropen/hoac009
  17. Dysmenorrhea: An update on primary healthcare management. Katie Christensen. AJPG Volume 53, Issue 1-2, January–February 2024. doi: 10.31128/AJGP/04-23-6815
  18. Rogers SK, Ahamadeen N, Chen CX, Mosher CE, Stewart JC, Rand KL. Dysmenorrhea and psychological distress: a meta-analysis. Arch Womens Ment Health. 2023 Dec;26(6):719-735. doi: 10.1007/s00737-023-01365-6. 
  19. Zhao S, Wu W, Kang R, Wang X. Significant Increase in Depression in Women With Primary Dysmenorrhea: A Systematic Review and Cumulative Analysis. Front Psychiatry. 2021 Aug 5;12:686514. doi: 10.3389/fpsyt.2021.686514.
  20. López-Liria R, Torres-Álamo L, Vega-Ramírez FA, García-Luengo AV, Aguilar-Parra JM, Trigueros-Ramos R, Rocamora-Pérez P. Efficacy of Physiotherapy Treatment in Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Jul 23;18(15):7832. doi: 10.3390/ijerph18157832.
  21. Shetty GB, Shetty B, Mooventhan A. Efficacy of Acupuncture in the Management of Primary Dysmenorrhea: A Randomized Controlled Trial. J Acupunct Meridian Stud. 2018 Aug;11(4):153-158. doi: 10.1016/j.jams.2018.04.001. 
  22. Matthewman G, Lee A, Kaur JG, Daley AJ. Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2018 Sep;219(3):255.e1-255.e20. doi: 10.1016/j.ajog.2018.04.001. 
  23. Woo HL, Ji HR, Pak YK, Lee H, Heo SJ, Lee JM, Park KS. The efficacy and safety of acupuncture in women with primary dysmenorrhea: A systematic review and meta-analysis. Medicine (Baltimore). 2018 Jun;97(23):e11007. doi: 10.1097/MD.0000000000011007. 
  24. Xu Y, Yang Q, Wang X. Efficacy of herbal medicine (cinnamon/fennel/ginger) for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. J Int Med Res. 2020 Jun;48(6):300060520936179. doi: 10.1177/0300060520936179.
  25. Wang L, Yan Y, Qiu H, Xu D, Zhu J, Liu J, Li H. Prevalence and Risk Factors of Primary Dysmenorrhea in Students: A Meta-Analysis. Value Health. 2022 Oct;25(10):1678-1684. doi: 10.1016/j.jval.2022.03.023.
  26. Leyland N, Casper R, Laberge P, Singh SS; SOGC. Endo­metriosis: diagnosis and management. J Obstet Gynae­col Can. 2010;32(7 suppl 2):S1-S32.
  27. Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol. 2003;17(1):75-92.
  28. Osayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. Am Fam Physician. 2014 Mar 1;89(5):341-6. PMID: 24695505
  29. Nie W, Xu P, Hao C, Chen Y, Yin Y, Wang L. Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea: A network meta-analysis. Medicine (Baltimore). 2020 May;99(19):e19881. doi: 10.1097/MD.0000000000019881
  30. Nie W, Xu P, Hao C, Chen Y, Yin Y, Wang L. Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea: A network meta-analysis. Medicine (Baltimore). 2020 May;99(19):e19881. doi: 10.1097/MD.0000000000019881
  31. Marjoribanks J, Proctor M, Farquhar C, Derks RS. Non­steroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2010;(1):CD001751.
  32. French L. Dysmenorrhea. Am Fam Physician. 2005;71(2): 285-291.
  33. American College of Obstetricians and Gynecolo­gists. ACOG practice bulletin no. 110: noncontracep­tive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206-218.
  34. Morrow C, Naumburg EH. Dysmenorrhea. Prim Care. 2009;36(1):19-32.
  35. Клинические рекомендации “Эндометриоз”. Российское общество акушеров-гинекологов. Год утверждения: 2020. URL: https://cr.minzdrav.gov.ru/schema/259_1
  36. Клинические рекомендации “Миома матки”. Российское общество акушеров-гинекологов. Год утверждения: 2020. URL: https://cr.minzdrav.gov.ru/recomend/257_1
  37. Клинические рекомендации “Воспалительные болезни женских тазовых органов”. Российское общество акушеров-гинекологов. Год утверждения: 2021. URL: https://cr.minzdrav.gov.ru/recomend/643_1
  38. Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril. 2018;110(6):1129-1136. doi: 10.1016/j.fertnstert.2018.07.003.
  39. Christensen K. Dysmenorrhoea: An update on primary healthcare management. Aust J Gen Pract. 2024 Jan-Feb;53(1-2):19-22. doi: 10.31128/AJGP/04-23-6815. PMID: 38316473.Ferries-Rowe E, Corey E, Archer JS. Primary dysmenorrhea: Diagnosis and therapy. Obstet Gynecol 2020;136(5):1047–58. doi: 10.1097/AOG.0000000000004096. 
  40. Khashchenko, E.P.; Uvarova, E.V.; Chuprynin, V.D.; Pustynnikova, M.Y.; Fatkhudinov, T.K.; Elchaninov, A.V.; Gardanova, Z.R.; Ivanets, T.Y.; Vysokikh, M.Y.; Sukhikh, G.T. Pelvic Pain, Mental Health and Quality of Life in Adolescents with Endometriosis after Surgery and Dienogest Treatment. J. Clin. Med. 2023, 12, 2400. https://doi.org/10.3390/jcm12062400
  41. Wang J, Deng K, Li L, Dai Y, Sun X. Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: Systematic review and meta-analysis of randomized controlled trials. Front Glob Womens Health. 2022;3:1013921. doi: 10.3389/fgwh.2022.1013921
  42. Fox MC, Klipping C, Nguyen AM, Frenkl TL, Cruz SM, Wang Y, Korver T. A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea. Contraception. 2019;99(2):125-130. doi: 10.1016/j.contraception.2018.10.009. 

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу